Universal marker and detection tool for human sarcoma circulating tumor cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24448245.
- Also identified by DOI 10.1158/0008-5472.CAN-13-1739 and PMC identifier 3959622.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To date, no specific marker exists for the detection of circulating tumor cells (CTC) from different types of sarcomas, though tools are available for detection of CTCs in peripheral blood of patients with cancer for epithelial cancers. Here, we report cell-surface vimentin (CSV) as an exclusive marker on sarcoma CTC regardless of the tissue origin of the sarcoma as detected by a novel monoclonal antibody. Utilizing CSV as a probe, we isolated and enumerated sarcoma CTCs with high sensitivity and specificity from the blood of patients bearing different types of sarcoma, validating their phenotype by single cell genomic amplification, mutation detection, and FISH. Our results establish the first universal and specific CTC marker described for enumerating CTCs from different types of sarcoma, thereby providing a key prognosis tool to monitor cancer metastasis and relapse.
Medical subject headings
- Biomarkers, Tumor
- Neoplastic Cells, Circulating
- Sarcoma
- Vimentin